R. Alshahi et al., SYSTEMIC LUPUS-ERYTHEMATOSUS, THROMBOCYTOPENIA, MICROANGIOPATHIC HEMOLYTIC-ANEMIA AND ANTI-CD36 ANTIBODIES, British journal of rheumatology, 36(7), 1997, pp. 794-798
Thrombocytopenia in patients with acute systemic lupus erythematosus (
SLE) frequently presents the clinician with considerable diagnostic an
d therapeutic difficulties. In this Grand Round, we present a 48-yr-ol
d woman with a 7 yr history of lupus, who presented with acute prolife
rative glomerulonephritis and nephrotic syndrome, pneumonia, profound
hypocomplementaemia and a severe microangiopathic haemolytic anaemia w
ith associated thrombocytopenia. Her thrombocytopenia proved initially
refractory to conventional immunosuppressive therapy, and corticoster
oids, and resolved only with plasma exchange and repeated fresh frozen
plasma infusions. Serological testing revealed high-titre antinuclear
antibodies (ANA) and markedly raised antibodies to double-stranded (d
s) DNA, but no significant elevation in anticardiolipin antibodies. Pl
atelet-associated Ige and IgM and antibodies to the CD36 glycoprotein
antigen, expressed on platelets and endothelium, were detected in the
serum. We address some of the difficult diagnostic and management issu
es raised by this complex patient and the possible immunopathological
links between antibodies to CD36, immune-mediated red cell destruction
, thrombocytopenia and thrombotic microangiopathic haemolytic anaemia.